Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Baseline pain severity as a pr...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis

Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis

Bibliographic Details
Main Authors: Ogdie, A, de Vlam, K, Bushmakin, A, Cappelleri, J, Mease, P, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J
Format: Conference item
Published: Wiley 2018
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
Summary:

Similar Items

  • Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
    by: de Vlam, K, et al.
    Published: (2018)
  • Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
    by: de Vlam, K, et al.
    Published: (2021)
  • Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
    by: Taylor, P, et al.
    Published: (2019)
  • Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
    by: de Vlam, K, et al.
    Published: (2022)
  • Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
    by: Taylor, PC, et al.
    Published: (2020)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs